Discovery, characterization, and significance of the cytochrome P450 ω-hydroxylase pathway of vitamin E catabolism

Annals of the New York Academy of Sciences

Volumn 1031, Issue , 2004, Pages 13-21

  Parker, Robert S ^a   Sontag, Timothy J ^a   Swanson, Joy E ^a   McCormick, Charles C ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Cytochrome P450; Cytotoxicity; Hepatocytes; Macrophage; Metabolism; Microsomes; Omega oxidation; Tocopherols; Vitamin E

Indexed keywords

4 CHROMANONE DERIVATIVE; ALKANE 1 MONOOXYGENASE; ALPHA TOCOPHEROL; CARBOXYCHROMANOL DERIVATIVE; CYTOCHROME P450; CYTOCHROME P450 4F2; CYTOCHROME P450 ISOENZYME; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ANIMAL CELL; BIOTRANSFORMATION; CANCER CELL CULTURE; CATABOLISM; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME SUBSTRATE; FATTY ACID OMEGA OXIDATION; GAS CHROMATOGRAPHY; HEPATOBLASTOMA; HUMAN; HUMAN CELL; LIVER MICROSOME; MACROPHAGE; MASS SPECTROMETRY; NONHUMAN; PROTEIN FUNCTION; RAT; URINARY EXCRETION; VITAMIN METABOLISM;

EID: 14944341755     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1331.002     Document Type: Conference Paper

References (12)

1. SWANSON, J., R. BEN, G. BURTON & R. PARKER. 1999. Measurement of the 2,7,8-trimethyl-2-(β-carboxyethyl)-6-hydroxychroman metabolite of γ-tocopherol in human urine: evidence for urinary excretion as a major route of elimination of γ-tocopherol. J. Lipid Res. 40: 665-671.
2. PARKER, R. & J. SWANSON. 2000. A novel 5′-carboxychroman metabolite of γ-tocopherol secreted by HepG2 cells and excreted in human urine. Biochem. Biophys. Res. Commun. 269: 580-583.
3. SONTAG, T. & R. PARKER. 2002. Cytochrome P450 w-hydroxylase pathway of tocopherol catabolism: novel mechanism of regulation of vitamin E status. J. Biol. Chem. 277: 25290-25296.
4. BIRRINGER, M., P. PFLUGER, D. KLUTH, et al. 2002. Identities and differences in the metabolism of tocotrienols and tocopherols in HepG2 cells. J. Nutr. 132: 31113-31118.
5. PELKONEN, O., J. MAENPAA, P. TAAVITSAINEN, et al. 1998. Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica 28: 1203-1253.
6. PARKER, R., T. SONTAG & J. SWANSON. 2000. Cytochrome P4503A-dependent metabolism of tocopherols and inhibition by sesamin. Biochem. Biophys. Res. Commun. 277: 531-534.
7. KIKUTA, Y., E. KUSUNOSE & M. KUSONOSE. 2002. Prostaglandin and leukotriene ω-hydroxylases. Prostaglandins Other Lipid Mediat. 68-69: 345-362.
8. SHIMIZU, S., K. AKIMOTO, Y. SHINMEN, et al. 1991. Sesamin is a potent and specific inhibitor of Δ5 desaturase in polyunsaturated fatty acid biosynthesis. Lipids 26: 512-516.
9. UMEDA-SAWADA, R., Y. FUIIWARA, H. ABE & Y. SEYAMA. 2003. Effects of sesamin and capsaicin on the mRNA expressions of D6 and D5 desaturases in rat primary cultured hepatocytes. J. Nutr. Sci. Vitaminol. 49: 442-446.
10. ROSS, A., Y. CHEN, J. FRANK, et al. 2004. Cereal alkylresorcinols elevate γ-tocopherol levels in male Sprague-Dawley rats and inhibit γ-tocopherol metabolism in vitro. J. Nutr. 143: 506-510.
11. YAMASHITA, K., Y. LIZUKA, T. IMAI & M. NAMIKI. 1995. Sesame seed and its lignans produce marked enhancement of vitamin E activity in rats fed a low α-tocopherol diet. Lipids 30: 1019-1028.
12. KAMAL-ELDIN, A, D. PETTERSSON & L.-A. APPELQUIST. 1995. Sesamin (a compound from sesame oil) increases tocopherol levels in rats fed ad libitum. Lipids 30: 499-505.